BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 18786708)

  • 21. Effect of subthalamic nucleus deep brain stimulation on axial motor control and protective arm responses in Parkinson's disease.
    Visser JE; Allum JH; Carpenter MG; Esselink RA; Limousin-Dowsey P; Honegger F; Borm GF; Bloem BR
    Neuroscience; 2008 Dec; 157(4):798-812. PubMed ID: 18952153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apraxia of eyelid opening after subthalamic deep brain stimulation may be caused by reduction of levodopa.
    Umemura A; Toyoda T; Yamamoto K; Oka Y; Ishii F; Yamada K
    Parkinsonism Relat Disord; 2008 Dec; 14(8):655-7. PubMed ID: 18316231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do health causal attributions and coping strategies act as moderators of quality of life in peritoneal dialysis patients?
    Pucheu S; Consoli SM; D'Auzac C; Français P; Issad B
    J Psychosom Res; 2004 Mar; 56(3):317-22. PubMed ID: 15046969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Staged bilateral deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease.
    Tanei T; Kajita Y; Kaneoke Y; Takebayashi S; Nakatsubo D; Wakabayashi T
    Acta Neurochir (Wien); 2009 Jun; 151(6):589-94. PubMed ID: 19381434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease.
    Volkmann J; Albanese A; Kulisevsky J; Tornqvist AL; Houeto JL; Pidoux B; Bonnet AM; Mendes A; Benabid AL; Fraix V; Van Blercom N; Xie J; Obeso J; Rodriguez-Oroz MC; Guridi J; Schnitzler A; Timmermann L; Gironell AA; Molet J; Pascual-Sedano B; Rehncrona S; Moro E; Lang AC; Lozano AM; Bentivoglio AR; Scerrati M; Contarino MF; Romito L; Janssens M; Agid Y
    Mov Disord; 2009 Jun; 24(8):1154-61. PubMed ID: 19412954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradykinesia in Parkinson's disease.
    Timmermann L; Braun M; Groiss S; Wojtecki L; Ostrowski S; Krause H; Pollok B; Südmeyer M; Ploner M; Gross J; Maarouf M; Voges J; Sturm V; Schnitzler A
    Mov Disord; 2008 Jan; 23(2):218-27. PubMed ID: 18044706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of pre-morbid depression on health-related quality of life in non-demented Parkinson's disease patients.
    Klepac N; Hajnsek S; Trkulja V
    Parkinsonism Relat Disord; 2010 Jan; 16(1):21-7. PubMed ID: 19640772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease.
    Bäumer T; Hidding U; Hamel W; Buhmann C; Moll CK; Gerloff C; Orth M; Siebner HR; Münchau A
    Mov Disord; 2009 Apr; 24(5):672-6. PubMed ID: 19185021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of levodopa and subthalamic nucleus stimulation on cognitive and affective functioning in Parkinson's disease.
    Funkiewiez A; Ardouin C; Cools R; Krack P; Fraix V; Batir A; Chabardès S; Benabid AL; Robbins TW; Pollak P
    Mov Disord; 2006 Oct; 21(10):1656-62. PubMed ID: 16830317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reoperation for suboptimal outcomes after deep brain stimulation surgery.
    Ellis TM; Foote KD; Fernandez HH; Sudhyadhom A; Rodriguez RL; Zeilman P; Jacobson CE; Okun MS
    Neurosurgery; 2008 Oct; 63(4):754-60; discussion 760-1. PubMed ID: 18981887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiparkinsonian therapy modifications in PD patients after STN DBS: a retrospective observational analysis.
    Zibetti M; Pesare M; Cinquepalmi A; Rosso M; Bergamasco B; Ducati A; Lanotte M; Lopiano L
    Parkinsonism Relat Disord; 2008 Dec; 14(8):608-12. PubMed ID: 18328768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subthalamic stimulation in Parkinson disease: behavior and social adaptation.
    Houeto JL; Mallet L; Mesnage V; Tezenas du Montcel S; Béhar C; Gargiulo M; Torny F; Pelissolo A; Welter ML; Agid Y
    Arch Neurol; 2006 Aug; 63(8):1090-5. PubMed ID: 16908734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health-related quality of life in Parkinson's disease after pallidotomy and deep brain stimulation.
    Straits-Tröster K; Fields JA; Wilkinson SB; Pahwa R; Lyons KE; Koller WC; Tröster AI
    Brain Cogn; 2000 Apr; 42(3):399-416. PubMed ID: 10753487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deep brain stimulation parameters associated with neuropsychological changes in subthalamic nucleus stimulation for refractory Parkinson's disease.
    Schoenberg MR; Mash KM; Bharucha KJ; Francel PC; Scott JG
    Stereotact Funct Neurosurg; 2008; 86(6):337-44. PubMed ID: 18854660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient-perceived involvement and satisfaction in Parkinson's disease: effect on therapy decisions and quality of life.
    Grosset KA; Grosset DG
    Mov Disord; 2005 May; 20(5):616-9. PubMed ID: 15719417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deep brain stimulation of the subthalamic nucleus and cognitive functions in Parkinson's disease.
    Klempírová O; Jech R; Urgosík D; Klempír J; Spacková N; Roth J; Růzicka E
    Prague Med Rep; 2007; 108(4):315-23. PubMed ID: 18780643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid resolution of dopamine dysregulation syndrome (DDS) after subthalamic DBS for Parkinson disease (PD): a case report.
    Knobel D; Aybek S; Pollo C; Vingerhoets FJ; Berney A
    Cogn Behav Neurol; 2008 Sep; 21(3):187-9. PubMed ID: 18797262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Globus pallidus stimulation improves both motor and nonmotor aspects of quality of life in advanced Parkinson's disease.
    Rodrigues JP; Walters SE; Watson P; Stell R; Mastaglia FL
    Mov Disord; 2007 Oct; 22(13):1866-70. PubMed ID: 17659634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subthalamic stimulation in Parkinson disease: with or without anesthesia?
    Maltête D; Navarro S; Welter ML; Roche S; Bonnet AM; Houeto JL; Mesnage V; Pidoux B; Dormont D; Cornu P; Agid Y
    Arch Neurol; 2004 Mar; 61(3):390-2. PubMed ID: 15023817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depressive symptoms impacting on health-related quality of life in early Parkinson's disease: results from Chinese L-dopa exposed cohort.
    Qin Z; Zhang L; Sun F; Liu H; Fang X; Chan P;
    Clin Neurol Neurosurg; 2009 Nov; 111(9):733-7. PubMed ID: 19665835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.